FTRE
Fortrea Holdings Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -15.4% ·
share flow +17.1% ·
net new positions -18.2%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | +8 | 73.98M | $1.29B | +12 | −4 |
| Q1 2026 | 100 | -4 | 67.95M | $640.51M | +5 | −9 |
| Q4 2025 | 104 | 0 | 71.13M | $1.23B | +1 | −1 |
| Q3 2025 | 18 | 0 | 53.25M | $448.39M | +2 | −2 |
| Q2 2025 | 15 | +1 | 46.90M | $231.21M | +1 | — |
| Q1 2025 | 11 | -2 | 16.99M | $128.27M | +1 | −3 |
| Q4 2024 | 13 | +3 | 14.50M | $270.52M | +4 | −1 |
| Q3 2024 | 9 | -2 | 13.45M | $268.92M | — | −2 |
| Q2 2024 | 11 | — | 13.76M | $321.15M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Starboard Value ✦ | 5.27M | -29.6% | $39.77M | 0.7% | ▼ Trim | 4 | SEC ↗ |
| 2 | Millennium Management ✦ | 3.50M | +466.4% | $26.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passive) | 3.26M | -3.2% | $24.64M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 1.58M | +5.9% | $11.95M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 1.58M | +5.9% | $11.95M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 1.10M | +181.9% | $8.27M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 1.10M | +181.9% | $8.27M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 1.10M | +181.9% | $8.27M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 1.10M | +181.9% | $8.27M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 1.10M | +181.9% | $8.27M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 1.06M | +505.9% | $8.02M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 1.06M | +505.9% | $8.02M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 399.41K | New | $3.02M | 0.0% | New | 1 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 385.50K | +19.7% | $2.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Marshall Wace ✦ | 227.13K | +1789.3% | $1.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Marshall Wace ✦ | 227.13K | +1789.3% | $1.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Marshall Wace ✦ | 227.13K | +1789.3% | $1.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 140.25K | +1.4% | $1.06M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 65.49K | +9.8% | $495,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Two Sigma Investments | $3.02M | 0.0% |
Exited
| Point72 Asset Management | $7.79M | was 0.0% |
| Norges Bank | $329,825 | was 0.0% |
| D. E. Shaw & Co. | $225,665 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 327 holders, 98.96M shares, $906.93M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 4.89K sh · $88,985
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology